ALAINA VINCENT: Open Payments
NPI 1689967747 · MEDIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,125 in 75 payments from 15 companies in 2025. Trend: 2023 $586 · 2024 $1,312 · 2025 $4,125
Consulting: $1,904Food & beverage: $1,741Travel & lodging: $479
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 17 | $1,834 |
| Janssen Biotech, Inc. | 16 | $1,445 |
| PFIZER INC. | 11 | $226 |
| Astellas Pharma US Inc | 8 | $172 |
| Novartis Pharmaceuticals Corporation | 6 | $125 |
| TOLMAR, INC. | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
Products named: ERLEADA, XTANDI, Nubeqa, PLUVICTO, JATENZO, KEYTRUDA, LYNPARZA, ORGOVYX.
Industry payments across PA — which companies pay providers there.
